CMPS: Depression Drug 86% Through Phase 3
CMPS' breakthrough-designated depression drug is 86% through its Phase 3 with topline data due this year
CMPS DFTX GHRS HELP - A Breakthrough-Designated Depression Drug Is 86% Through Its Phase 3, With Topline Data Due This Year